Myriad Genetics MYGN
NASDAQ MYGN
$4.54 +0.48 (+11.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Myriad Genetics (MYGN) Liabilities from Discontinued Operations (2024)

Updated

Myriad Genetics (MYGN) recorded Liabilities from Discontinued Operations of $4 million in Q2 2024.

Analysis

Myriad Genetics (MYGN) Liabilities from Discontinued Operations (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn
6 Tenet Healthcare 20.83 Bn 11.98 Bn -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn
9 Encompass Health 11.82 Bn 12.29 Bn -
10 Myriad Genetics 434.02 Mn -100.58 Mn 127.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 4.00 Mn
API Access

Myriad Genetics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=MYGN&period=max&api_key=YOUR_API_KEY